NCT00315653View on ClinicalTrials.gov

Survivin Urine mRNA Assay Risk of Bladder Cancer Study

CompletedOBSERVATIONAL
Enrollment

600

Participants

Timeline

Start Date

September 30, 2005

Study Completion Date

November 30, 2007

Conditions
Bladder Cancer
Trial Locations (1)

19355

Fujirebio Diagnostics, Inc, Malvern

Sponsors
All Listed Sponsors
lead

Fujirebio Diagnostics, Inc.

INDUSTRY